2025
Acute Adenosine Receptor Antagonism in Combination With Acute Intermittent Hypoxia to Promote Breathing Plasticity in Amyotrophic Lateral Sclerosis: Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial
JMIR Research Protocols
Treats Adults
Michael T Pulley, MD, PhD
Neurologist, Clinical Neurophysiologist, Neuromuscular Medicine Physician
Michael T Pulley, MD, PhD
(904) 383-1022
Request appointment online
My publications
Filter publications
22 publications
2025
First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumab.
Journal of the neurological sciences
鈥�2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
The Lancet. Neurology
鈥�2025
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Muscle & nerve
鈥�2023
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Amyotrophic lateral sclerosis & frontotemporal degeneration
鈥�